The Effect of Diluted Deoxycholic Acid on Arm Fat Reduction: Evaluation of Its Potential in Minimally Invasive Fat Loss Treatment
Journal of Cosmetic Dermatology · 2025-03 · 24 (3)
DOI: 10.1111/jocd.70088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 27.02.2025. Verfasst von Ji Yeon Hong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Deoxycholic Acid, Subcutaneous Fat. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Trade, Industry & Energy (MOTIE, Korea).
Abstract (Originalsprache)
Background
Deoxycholic acid (DCA) at a concentration of 10 mg/mL is commonly used for localized fat reduction, but its application in larger areas like the upper arm can lead to higher costs and discomfort. Diluting DCA may provide a cost‐effective solution with reduced pain while still maintaining efficacy.
Objective
This case series aims to evaluate the efficacy, safety, and overall cost‐effectiveness of diluted DCA injections at concentrations of 5 mg/mL and 2.5 mg/mL for upper arm fat reduction.
Methods
Four healthy adult females received subcutaneous injections of either 5 mg/mL or 2.5 mg/mL DCA, administered three times at four‐week intervals. Arm circumference and subcutaneous fat thickness were measured at baseline and at 4, 8, 12, and 20 weeks using tape measures and ultrasonography. Pain levels and patient satisfaction were also assessed to gauge the overall balance between treatment efficacy, side effects, and costs.
Results
Both 5 mg/mL and 2.5 mg/mL concentrations led to significant reductions in subcutaneous fat thickness, with the 5 mg/mL group showing slightly greater reductions. However, changes in arm circumference were minimal across both groups. Pain levels were higher in the 5 mg/mL group, while the 2.5 mg/mL group experienced less discomfort. Importantly, both concentrations demonstrated a balance between efficacy and treatment cost, with the diluted solutions providing a less invasive alternative to the standard 10 mg/mL concentration.
Conclusion
This case series represents diluted DCA injections, both at 5 mg/mL and 2.5 mg/mL, offering viable minimally invasive options for upper arm fat reduction. While the 5 mg/mL concentration shows slightly greater efficacy, the 2.5 mg/mL option may offer a more comfortable treatment experience. The choice of concentration can be tailored to patient priorities, balancing fat reduction, pain tolerance, and cost considerations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
- Songpajeil Orthopedic Clinic, Seoul, Republic of Korea.
- Yemiwon Dermatologic Clinic, Seoul, Republic of Korea.
ORCID-Profile: Kui Young Park
Förderung
- the Ministry of Trade, Industry & Energy (MOTIE, Korea)
Zitieren
APA
Hong, J. Y., Lee, Y. H., Yeoum, S. H., Youn, C. S., & Park, K. Y. (2025). The Effect of Diluted Deoxycholic Acid on Arm Fat Reduction: Evaluation of Its Potential in Minimally Invasive Fat Loss Treatment. Journal of Cosmetic Dermatology, 24(3). https://doi.org/10.1111/jocd.70088
Vancouver
Hong JY, Lee YH, Yeoum SH, Youn CS, Park KY. The Effect of Diluted Deoxycholic Acid on Arm Fat Reduction: Evaluation of Its Potential in Minimally Invasive Fat Loss Treatment. Journal of Cosmetic Dermatology. 2025;24(3). doi:10.1111/jocd.70088
BibTeX
@article{Hong2025,
author = {Hong, Ji Yeon and Lee, Yoon Hwan and Yeoum, Seung Hoon and Youn, Choon Shik and Park, Kui Young},
title = {The Effect of Diluted Deoxycholic Acid on Arm Fat Reduction: Evaluation of Its Potential in Minimally Invasive Fat Loss Treatment},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {3},
doi = {10.1111/jocd.70088}
}
EUVIMED